TSE treatments at the Royal Veterinary College shows very promising results
Scandinavian ChemoTech’s fully owned subsidiary Vetiqure receives very promising updates from the veterinarians at the Royal Veterinary College (RVC), who will now continue to treat more patients.The first horse has a severe fibroblastic sarcoid on the pastern which has previously been treated with a combination of surgical debridement and the older static electroporation device. This resulted in improvement but not complete resolution. The veterinarians at the RVC are now receiving encouraging progress updates from the owner following TSE treatment: “Looking much better today, particularly